GL1X · GenesisL1 explorer

Research workbench

Sar development and discovery of potent indole-based inhibitors of the hepatitis C virus NS5B polymerase

Analyse Sar development and discovery of potent indole-based inhibitors of the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3TYV
Type
protein
Length
1,121 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
HI3, PO4
Pockets
16 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56349% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55849% helix, 15% strandO92972

Ligands and binding sites

  • HI3 · N-(cyclopropylsulfonyl)-1-(2,5-difluorobenzyl)-6-fluoro-5-methyl-3-(2-oxo-1,2-dihydropyridin-3-yl)-1H-indole-2-carboxamide · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111330.810.8285HI3
211030.800.8184HI3
31070.510.8220empty
41210.490.8018empty
51180.460.7821empty

Interfaces

1 interface between chains.

  • A–B · 996 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 3TYV · SAR development and discovery of potent indole-based inhibitors of the hepatitis C virus… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.